Feasibility, usability and acceptance of weekly electronic patient-reported outcomes among patients receiving pelvic CT- or online MR-guided radiotherapy - A prospective pilot study

被引:6
|
作者
Moller, P. K.
Pappot, H. [3 ,4 ]
Bernchou, U. [2 ,5 ]
Schytte, T. [2 ,6 ]
Mortensen, Z. V. [6 ]
Brunni, M. F. A. [6 ]
Dieperink, K. B. [1 ,2 ]
机构
[1] Odense Univ Hosp, Acad Geriatr Canc Res, Dept Oncol, AgeCare, Odense, Denmark
[2] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[3] Univ Hosp Copenhagen, Rigshosp, Dept Oncol, Copenhagen, Denmark
[4] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[5] Odense Univ Hosp, Lab Radiat Phys, Odense, Denmark
[6] Odense Univ Hosp, Dept Oncol, Odense, Denmark
来源
TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY | 2022年 / 21卷
关键词
Patient -reported outcome (PRO); Radiotherapy; Online MRgRT; Feasibility; Usability; Acceptance; COMMON TERMINOLOGY CRITERIA; EVENTS PRO-CTCAE; ADVERSE EVENTS; CANCER-TREATMENT; TOXICITY; ONCOLOGY; CHEMORADIOTHERAPY; INTERVENTION; PERSPECTIVE; CLINICIAN;
D O I
10.1016/j.tipsro.2021.12.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The potential of patient symptoms being monitored longitudinally in radiotherapy (RT) is still unexploited. When novel technologies like online adaptive MR-guided radiotherapy (MRgRT) are evaluated, weekly electronic patient-reported outcomes (ePROs) may add knowledge about the symptom trajectory. This study aimed at evaluating feasibility, usability and acceptance of weekly ePRO among patients receiving pelvic radiotherapy. Materials and Methods: In a mixed-methods convergent design, a prospective pilot study enrolled patients referred to pelvic radiotherapy with curative intent. Patients used their own device at home to self-report PRO weekly during and four weeks following radiotherapy and week 8, 12, and 24 (paper-questionnaire as an alternative). Feasibility was extracted from the ePRO software. The Patient Feedback Form and patient interviews were used to explore usability and patient acceptance. Patients were informed that clinicians had no access to PRO responses. Results: In total, 40 patients were included; 32 patients with prostate cancer and 8 with cervical cancer (consent rate 87%), median age 68 (36-76). The majority did digital reporting (93%). 85% of patients responded to >= 80% of the weekly questionnaires with 91% average adherence to weekly completion (60% for follow-up), although lower for patients >= age 70. Time spent on ePRO (97%) and frequency of reporting (92%) was considered appropriate. Interviews (n = 14) revealed the application was usable and the patients requested real-time feedback from the clinicians. Conclusion: Recruitment for ePRO during radiotherapy was feasible and adherence to weekly self-reporting high. The digital application was usable and weekly frequency and time spent acceptable. Real-time feedback from the clinicians is requested by the patients.
引用
收藏
页码:8 / 15
页数:8
相关论文
共 4 条
  • [1] Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes
    Mazzola, Rosario
    Figlia, Vanessa
    Rigo, Michele
    Cuccia, Francesco
    Ricchetti, Francesco
    Giaj-Levra, Niccolo
    Nicosia, Luca
    Vitale, Claudio
    Sicignano, Gianluisa
    De Simone, Antonio
    Naccarato, Stefania
    Ruggieri, Ruggero
    Alongi, Filippo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2379 - 2397
  • [2] Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial
    Fink, C. A.
    Ristau, J.
    Buchele, C.
    Klueter, S.
    Liermann, J.
    Hoegen-Sassmannshausen, P.
    Sandrini, E.
    Lentz-Hommertgen, A.
    Baumann, L.
    Andratschke, N.
    Baumgartl, M.
    Li, M.
    Reiner, M.
    Corradini, S.
    Hoerner-Rieber, J. Ho
    Bonekamp, D.
    Schlemmer, H. -P.
    Belka, C.
    Guckenberger, M.
    Debus, J.
    Koerber, S. A.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 46
  • [3] Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study
    Offodile, Anaeze C., II
    DiBrito, Sandra R.
    Finder, Janice P.
    Shete, Sanjay
    Jain, Sanchita
    Delgado, Domenica A.
    Miller, Christopher J.
    Davidson, Elenita
    Overman, Michael J.
    Peterson, Susan K.
    BMJ OPEN, 2022, 12 (04):
  • [4] 18F-fluorodeoxyglucose PET-CT-guided pelvic chemoradiation therapy using helical tomotherapy for locally advanced carcinoma cervix without para-aortic nodal disease: Clinical and patient-reported outcomes from a prospective phase 2 study
    Achari, Rimpa Basu
    Chakraborty, Santam
    Ray, Soumendranath
    Mahata, Anurupa
    Mandal, Samar
    Das, Jayanta
    Sarkar, Kanishka
    Mallick, Indranil
    Bhaumik, Jaydip
    Chakraborti, Basumita
    Ghosh, Anik
    Sen, Saugata
    Chandra, Aditi
    Chatterjee, Sanjoy
    Arunsingh, Moses
    Bhattacharyya, Tapesh
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2024, 68 (05) : 624 - 634